Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
Benign Prostatic Hyperplasia
HYPERPLASIA
John S Kachimba
Department of Surgery
BENIGN PROSTATIC
HYPERPLASIA
BPH is the commonest benign
tumour in in men.
Prevalence approaches 100% by 80
years.
BPH is characterized by an increase
both stromal and glandular elements
of the prostate.
TERMINOLOGY
AIMS OF TREATMENT:
1. Relieve urinary symptoms.
2. Improve quality of life.
3. Reduce the complications of
bladder outflow obstruction.
TREATMENT OPTIONS FOR
BPH
1. Active monitoring or ‘Watchful
waiting’.
2. Pharmacological treatment.
3. Minimally invasive therapies.
4. Conventional surgery.
Watchful Waiting